TRIB news> Trinity Biotech has acquired the specialty clinical chemistry business that consists of several esoteric products that are clearly differentiated in the marketplace. This product line is made up of the following products: ACE, Bile Acids, Lactate, Oxalate, and G6PDH. Many of these products are single source products and will only be available from Trinity Biotech. Also included in the transaction, the terms of which were not disclosed, were the HDL, LDL and Lipase product lines. Moreover, Trinity Biotech gains the rights to an HbA1c product that is FDA cleared but not currently on the market.
JMAR suddenly looking better, t/a wise
stockcharts.com[h,a]daclyiay[pc13!d20,2!f][vc60][iUa12,26,9!Lf]&pref=G |
